3,693.57 (1,258.59) (34.1) Profit before FX 532.44 2,175.99 (1,643.55) (75.5) 2,516.29 3,879.22 (1,362.93) (35.1) * excluding fuel cost Quarter 2 6-Month Increase (Decrease) % Increase (Decrease) % The

has been reviewed by the Auditor. The overall of the Company’s performance can be summarised as follows: Performance (Income Statement) Q2/2020 Q2/2019 Increase/(decrease) % Revenue Revenue from sales

December 2019 Increase (Decrease) % Net Assets 6,213 5,885 328 5.57 Net Liabilities 2,433 2,076 357 17.20 Shareholders’ equity 3,780 3,809 (29) (0.76) Assets As at December 31, 2020, the Company and its

and the three-month period ended March 31, 2020, respectively. The figures represent a period-on-period increase of 5.36% due mainly to an increasing in number of patients. Cost of hospital operations

Position As at 31 March 2020, total consolidated assets of the Company and its subsidiary increased by Baht 68.58 million or 2.33% compared with last year. An increase mainly caused by Right-of-use assets

and manage the inventory at the factory warehouses caused an expense of Baht 44.8 million, an increase of 2.3%.  Allowance for the Decline in Value of Inventory Allowance for the decline in value of

Unit: Million Baht Projects Consolidated Revenue Project Revenue Increase (Decrease) % Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) Revenue (Million Baht) 31th-Mar-20 31th-Mar-19

in domestic and international Registered Capital : 1,000,000 Baht (Megawatt will increase capital to 2,500 million baht in the future) Board’s Structure : 1. Mr. Thammarat Saengchan 2. General Chaiwat

in domestic and international Registered Capital : Baht 1,000,000 with a par value of Baht 100 per share (the Joint Venture will increase capital to Baht 1,763 million within year 2020) Board’s

profit and net profit margin increased due to the increase in sales as well as an increase of gross profit margin. Financial position Unit: Million Baht As at As at Change September 30, 2020 September 30